Apreo Health
Menlo Park, US · 36 employees on LinkedIn · 4 known investors
Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function. The company targets patients with severe emphysema who have limited treatment options.
Founders & leadership
KD
Karun Durgam NagaFounder
Board
HS
Hanson S. Gifford IIIBoard director
ZS
Zack ScottBoard director
MA
Michael A. CarusiBoard director
DF
Drew FieldBoard director
DM
Dennis McWilliamsBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$81.8M disclosed across 1 round · 2025
▶$81.8MraisedAug 2025 · 7 investors · Other Health CareRule 506(b)
▶$81.8MraisedAug 2025 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Karun Durgam NagaExecutive Officer, Director
- Drew FieldDirector
- Dennis McWilliamsDirector
- Hanson S. Gifford IIIDirector
- Zack ScottDirector
- Michael A. CarusiDirector
- Offering amount
- $130.6M
- Amount sold
- $81.8M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Veeva4 shared keywordsVeeva Clinical Platform is a cloud-based suite of connected applications for running clinical trials, covering clinical operations, clinical data, research sites, and patients. It serves biopharma sponsors, clinical research sites, and patients across trial management, data capture, and disclosures.
Power4 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Proprio4 shared keywordsProprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT. The system is built for hospitals and health systems to increase surgical capacity, standardize performance, and support clinical training through an AI foundation model trained on data from hundreds of surgeons.
Reperio Health3 shared keywordsReperio Health builds diagnostic tools and automated systems powered by AI/ML for enterprise deployment, with infrastructure for real-time data processing. The company serves large enterprises across technology and other sectors.
Companies competing with Apreo Health for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Apreo Health do?
- Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function. The company targets patients with severe emphysema who have limited treatment options.
- Who founded Apreo Health?
- Apreo Health was founded by Karun Durgam Naga.
- Who are Apreo Health's investors?
- Apreo Health's investors include F-Prime Capital, Intuitive Ventures, Lightstone Ventures, Norwest Venture Partners.
- How much funding has Apreo Health raised?
- Apreo Health has disclosed $81.8M raised across 1 round.
- Where is Apreo Health headquartered?
- Apreo Health is headquartered in Menlo Park, US.